Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.
Take a look at the Top Ten Companies also in the race and where their products are in the clinical trial development phase.
Data for this infographic has been extracted from Informa Pharma Intelligence’s products Biomedtracker –tracking drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets, and Pharmaprojects - offering end-to-end tracking of the global pharma R&D pipeline from bench to patient, including company development trends, global development status, and therapeutic class status.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: